INVESTIGADORES
GARGIULO Pascual Angel
artículos
Título:
52) The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
Autor/es:
MURGA, I.; ARANBURU, L. ; GARGIULO, P.A.; GOMEZ ESTEBAN, J.C.; LAFUENTE, J.V.
Revista:
JOURNAL OF TRANSLATIONAL MEDICINE
Editorial:
BIOMED CENTRAL LTD
Referencias:
Lugar: Londres; Año: 2021
ISSN:
1479-5876
Resumen:
0052) Murga I, Aranburu L, Gargiulo PA, Gómez-Esteban JC, Lafuente JV. The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker? J Transl Med. 2021 Dec 4; 19(1): 494. doi: 10.1186/s12967-021-03153-1. PMID: 34863209; PMCID: PMC8645147. ISSN: 1479-5876Abstract.The maintained attention is the cause of great functional limitations in CFS/ME, a disease that mainly affects women in the central period of life. Cognitive function is explored using the Montreal Cognitive Assessment, the maintained attention using the Toulouse-Piéron test with which the Global Index of Attention and Perception (GIAP) is obtained, the fatigue using the visual analog scale and the perception of effort using the modified Borg scale. The final sample were 84 patients (66 women/18 men) who met diagnostic criteria (Fukuda-1994, Carruthers-2011) and 22 healthy controls (14 women/8 men). Most of patients maintain normal cognitive function, showing low or very low attention score in the 70% of patients with a marked cognitive fatigue compared to the control group (p < 0.05). There were no significant differences between genders in GIAP or fatigue for CFS/ME; however, sick women perceive cognitive effort higher than men. Deficits in sustained attention and the perception of fatigue, so effort after performing the proposed test are a sensitive and reliable indicator that allows us to substantiate a clinical suspicion and refer patients for further studies in order to confirm or rule out CFS/ME.Keywords: Maintained attention; Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Toulouse-Piéron test.